Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Nurofen Pain Relief 256mg tablets
1001010APBCAAAA
|
Nurofen (Ibuprofen sodium dihydrate) | Ibuprofen sodium dihydrate | Musculoskeletal and Joint Diseases | 1 |
|
Nurofen Pain Relief 256mg caplets
1001010APBCACAA
|
Nurofen (Ibuprofen sodium dihydrate) | Ibuprofen sodium dihydrate | Musculoskeletal and Joint Diseases | No data available |
|
Nurofen Pain Relief Max Strength 512mg tablets
1001010APBCABAB
|
Nurofen (Ibuprofen sodium dihydrate) | Ibuprofen sodium dihydrate | Musculoskeletal and Joint Diseases | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.